Cartesian Therapeutics Inc (RNAC)
EBITDA Margin
-10671.90%
TTM · Period ending:
RNAC EBITDA Margin
Latest reported-10671.90%period ending
Latest reported-10671.90%period ending
RNAC EBITDA Margin (-377.11% → -10671.90%)
Annual ebitda margin
High-resolution chart · PNG
RNAC ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -4,881.5159% | |
| -195.2715% | |
| -903.8379% | |
| 35.2853% | |
| -6.6117% | |
| -401.193% | |
| -775.8574% | |
| -6,962.0155% | |
| -30,611.1111% | |
| -422.5535% | |
| -385.6596% | |
| -377.1053% |